Kintor Pharmaceutical gets EUA for Covid drug proxalutamide in Paraguay
Kintor Pharmaceutical has secured an emergency use authorization (EUA) for proxalutamide (GT-0918) for the treatment of hospitalized patients with Covid-19 infections in Paraguay. The EUA issued by the Ministry of Public Health and Social Welfare (MSPBS) is for the use of the nonsteroidal antiandrogen in patients admitted in MSPBS hospitals. The Barrio Obrero hospital, which […]